Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 5/20 | 0.43 |
| ▸ | EGFR | P00533 | 3/20 | 0.43 |
| ▸ | ABL1 | P00519 | 2/20 | 0.40 |
| ▸ | ABL2 | P42684 | 2/20 | 0.40 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.38 |
| ▸ | DTYMK | P23919 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8639265 | 1.00 | SRC (0.43) | SRCEGFRABL1ABL2HCAR1 | |
| SCHEMBL8640829 | 0.88 | EGFR (0.42) | SRCEGFRMAPTGPR119 | |
| SCHEMBL8638733 | 0.88 | EGFR (0.42) | SRCEGFRMAPTGPR119 | |
| SCHEMBL14193 | 0.80 | SRC (0.44) | SRCEGFRABL1ABL2HCAR1 | |
| SCHEMBL30087102 | 0.73 | HCAR1 (0.51) | SRCEGFRABL1ABL2HCAR1 | |
| SCHEMBL13968 | 0.73 | HCAR1 (0.51) | SRCEGFRABL1ABL2HCAR1 | |
| SCHEMBL21811121 | 0.73 | KDM4E (0.45) | SRCEGFRABL1ABL2HCAR1 | |
| SCHEMBL8300808 | 0.72 | TK1 (0.39) | — | |
| SCHEMBL8304127 | 0.72 | TK1 (0.39) | — | |
| SCHEMBL8298155 | 0.72 | TK1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0646596-B1 | Nucleic acid binding oligomers having C-branches for therapy and diagnosis | BAYER AG (DE) | 1999-05-26 | — | — | EP | disclosed |
| US-5849893-A | Nucleic acid-binding oligomers possessing C-branching for therapy and diagnostics | BAYER AKTIENGESELLSCHAFT (DE) | 1998-12-15 | — | — | US | disclosed |
| EP-0646596-A1 | Nucleic acid binding oligomers having C-branches for therapy and diagnosis | BAYER AG (DE) | 1995-04-05 | — | — | EP | disclosed |